On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. RRC saying natural gas is the weakest part of the petrol chain.
Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc GH.
He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.
Seattle Genetics, Inc. SGEN is a buy, says Cramer.
Cramer says to steer clear of Zynerba Pharmaceuticals Inc ZYNE and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR GWPH is what he would buy.
Related Links:
'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!